The Journal of Organic Chemistry
Page 12 of 16
(Cquat), 139.6 (Cquat), 142.7 (Cquat), 142.9 (CH), 152.3 (Cquat), calcd. for C23H20Cl2N4 (423.3): C 65.25, H 4.76, N 13.22;
153.4 (Cquat). EI + MS (m/z (%)): 301 (M+, 48), 300 (12), 232
(45), 231 ([M-C4H8N]+, 100), 224 (29), 219 (12), 218 ([M-
C5H8N]+, 30), 149 (17), 116 (13), 96 (16), 84 (10), 83 (11), 77
(13), 72 (28), 71 (33), 70 (10), 57 (16), 56 (12), 55 (10). IR: ν
3057 (w), 2957 (w), 2853 (w), 1612 (m), 1522 (m), 1497 (w),
1475 (m), 1456 (w), 1441 (w), 1379 (m), 1364 (m), 1335 (m),
1298 (m), 1277 (m), 1252 (m), 1221 (w); 1179 (w), 1150 (m),
1113 (m), 1076 (w), 1034 (w), 1015 (m), 957 (m), 907 (w), 874
(w), 843 (w), 810 (w), 762 (s), 733 (w), 696 (s), 687 (m),
658 (w), 608 (m) [cm-1]. Anal. calcd. for: C20H19N3 (301.2):
C 79.70, H 6.35, N 13.94. Found: C 79.91, H 6.45, N 13.82.
Found: C 65.54, H 4.59, N 13.22.
1
2
3
4
5
6
7
8
(E)-6,7-dichloro-2-phenyl-3-(2-(pyrrolidin-1-
yl)vinyl)quinoxaline (9g). Dark-red solid (382 mg, 52%),
1
̃
Mp 164 °C. H NMR (CDCl3, 300 MHz):
δ 1.86-2.00 (m, 4
H), 3.32 (s, 4 H), 5.24 (d, J = 12.5 Hz, 1 H), 7.39-7.56 (m, 3
H), 7.59-7.74 (m, 2 H), 7.88 (s, 1 H), 7.98 (s, 1 H), 8.13 (d, J
= 12.2 Hz, 1 H). 13C NMR (CDCl3, 75 MHz):
δ 25.2 (CH2),
47.8-50.7 (CH2), 92.8 (CH), 127.3 (CH) 128.4 (CH), 128.85
(CH), 128.93 (CH), 129.0 (Cquat), 129.5 (CH), 133.3 (Cquat),
137.9 (Cquat), 138.9 (Cquat), 144.2 (CH), 153.0 (Cquat), 154.6
(Cquat). EI + MS (m/z (%)): 371 ([M{37Cl,35Cl}]+, 26), 370
(16), 369 ([M{35Cl,35Cl}]+, 39), 368 (12), 303 ([M{37Cl,37Cl}-
C4H8N]+, 16), 302 (35), 301 ([M{37Cl,35Cl}-C4H8N]+, 70), 300
(56), 299 ([M{35Cl,35Cl}-C4H8N]+, 100), 294 ([M{37Cl,35Cl}-
C6H5]+, 17), 292 ([M{35Cl,35Cl}-C6H5]+, 26), 288
([M{37Cl,35Cl}-C5H9N]+,16), 287 (13), 286 ([M{35Cl,35Cl}-
C5H9N]+, 22), 264 (18), 150 (12), 96 (C6H10N+, 18), 84 (13), 70
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(E)-2-(2-(Pyrrolidin-1-yl)vinyl)-3-(thiophen-2-yl)quinoxaline
(9e). Red solid (452 mg, 69%), Mp 135 °C. 1H NMR (CDCl3,
300 MHz):
δ 1.83-2.09 (m, 4 H), 3.24-3.60 (br, 4 H), 5.75
(d, J = 12.6 Hz, 1 H), 7.15 (dd, J = 5.1 Hz, J = 3.6 Hz, 1 H),
7.42 (ddd, J = 8.3 Hz, J = 6.9 Hz, J = 1.4 Hz, 1 H), 7.48 (dd, J
= 5.1 Hz, J = 1.0 Hz, 1 H), 7.55 (ddd, J = 8.4, Hz, J = 6.9 Hz, J
= 1.5 Hz, 1 H), 7.73 (dd, J = 3.7 Hz, J = 1.1 Hz, 1 H), 7.75-7.84
(br, 1 H), 7.84-7.93 (m, 1 H), 8.17 (d, J = 12.6 Hz, 1 H). 13C
(11). IR: ν̃ 2953 (w), 2851 (w), 1609 (m), 1539 (w), 1516 (s),
1506 (s), 1495 (m), 1477 (m), 1452 (m), 1443 (m), 1416 (w),
1371 (m), 1333 (m),1312 (m), 1302 (m), 1277 (m), 1260 (m),
1244 (m), 1219 (m), 1207 (m), 1180 (w), 1146 (s), 1103 (m),
1076 (m), 1036 (m),1013 (m), 999 (m), 978 (m), 959 (m),
920 (m), 908 (w), 885 (m), 860 (m), 810 (m), 773 (m), 760
(m), 719 (m), 696 (s), 675 (m), 650 (m), 631 (m) [cm-1].
Anal. calcd. for C20H17Cl2N3 (370.3): C 64.88, H 4.63, N
11.35; gef.: C 64.80, H 4.55, N 11.23.
NMR (CDCl3, 75 MHz):
δ 25.3 (CH2), 48.5-50.2 (CH2), 92.8
(CH), 126.0 (CH), 126.8 (CH), 127.3 (CH), 127.9 (CH), 128.1
(CH), 128.7 (CH), 129.4 (CH), 139.0 (Cquat), 141.4 (Cquat),
142.8 (Cquat), 143.8 (CH), 146.4 (Cquat), 151.5 (Cquat). EI + MS
(m/z (%)): 308 (15), 307 (M+, 70), 306 (16), 274 (15), 262
(11), 239 (13), 238 (52), 237 ([M-C4H8N]+, 100), 224 ([M-
C5H9N]+, 22), 205 (11). IR: ν
̃ 3073 (w), 2963 (w), 1612 (s),
1599 (s), 1509 (s), 1504 (s), 1476 (m), 1452 (m), 1425 (m),
1377 (s), 1360 (m), 1341 (m), 1331 (m), 1288 (m), 1277 (s),
1219 (m), 1152 (m), 1111 (m), 1072 (m), 1015 (m), 957 (m),
937(w), 761 (s), 750 (s), 738 (s), 710 (s), 608 (s) [cm-1]. Anal.
calcd. for: C18H17N3S (307.4): C 70.35, H 5.57, N 13.67, S
10.43. Found: C 70.23, H 5.63, N 13.47, S 10.37.
(E)-6,7-dichloro-2-(2-(pyrrolidin-1-yl)vinyl)-3-(thiophen-2-
yl)quinoxaline (9h). Red solid (486 mg, 65%), Mp 163 °C.
1H NMR (CDCl3, 300 MHz):
δ 1.85-2.08 (m, 4 H), 3.41 (br, 4
H), 5.71 (d, J = 12.5 Hz, 1 H), 7.14 (dd, J = 5.1 Hz, J = 3.7 Hz, 1
H), 7.49 (dd, J = 5.1 Hz, J = 1.1 Hz, 1 H), 7.74 (dd, J = 3.7 Hz,
J = 1.1 Hz, 1 H), 7.81 (s, 1 H), 7.94 (s, 1 H), 8.15 (d, J = 12.5
Hz, 1 H). 13C NMR (CDCl3, 75 MHz):
δ 25.3 (CH2), 47.0-
(E)-6,7-dichloro-2-(1-methyl-1H-indol-3-yl)-3-(2-(pyrrolidin-
1-yl)vinyl)quinoxaline (9f). Red solid (578 mg, 68%), Mp
53.0 (CH2), 92.5 (CH), 127.3 (CH), 127.4 (CH), 128.4 (CH),
128.5 (CH), 129.1 (CH), 129.2 (Cquat), 133.1 (Cquat), 137.7
(Cquat), 140.5 (Cquat), 142.5 (Cquat), 144.6 (CH), 147.3 (Cquat),
152.3 (Cquat). EI + MS (m/z (%)): 378 (10), 377 (M{37Cl,
35Cl}+, 44), 376 (21), 375 (M{35Cl, 35Cl}+, 61), 374 (13), 344
(10), 342 (16), 309 ([M{37Cl, 37Cl}-C4H8N]+, 21), 308 (44),
307 ([M{37Cl, 35Cl}-C4H8N]+, 80), 306 (68), 305 ([M{35Cl,
35Cl}-C4H8N]+, 100), 294 ([M{37Cl, 35Cl}-C5H9N]+, 15), 292
([M{35C, 35Cl}-C5H9N]+, 21), 273 (13), 269 (11), 153 (10), 96
1
156 °C. H NMR (CDCl3, 300 MHz):
δ 1.82-2.01 (m, 4 H),
3.30 (br, 4 H), 3.88 (s, 3 H), 5.61 (d, J = 12.6 Hz, 1 H), 7.21
(ddd, J = 8.0 Hz, J = 7.0 Hz, J = 1.2 Hz, 1 H), 7.30 (ddd, J =
8.1 Hz, J = 6.9 Hz, J = 1.2 Hz, 1 H), 7.39 (d, J = 8.1 Hz, 1 H),
7.64 (s, 1 H), 7.85 (s, 1 H), 7.97 (s, 1 H), 7.97 (d, J = 7.9 Hz, 1
13
H), 8.16 (d, J = 12.8 Hz, 1 H). C NMR (CDCl3, 75 MHz):
δ
25.2 (CH2), 33.1 (CH3), 48.0-50.28 (br, CH2), 93.7 (CH),
109.5 (CH), 114.0 (Cquat), 120.3 (CH), 122.0 (CH), 122.4 (CH),
127.0 (Cquat), 127.4 (CH), 128.7 (Cquat), 129.0 (CH), 130.6
(CH), 132.0 (Cquat), 137.2 (Cquat), 138.3 (Cquat), 140.2 (Cquat),
144.0 (CH), 150.0 (Cquat), 153.6 (Cquat). EI + MS (m/z (%)):
424 (M+{37Cl, 35Cl}, 10), 422 (M+{35Cl, 35Cl}, 15), 357 (10), 356
([M{37Cl, 37Cl}-C4H8N]+, 18), 355 (62), 354 ([M{37Cl, 35Cl}-
C4H8N]+, 57), 353 (100), 352 ([M{35Cl, 35Cl}-C4H8N]+, 65),
351 (12), 340 (12), 339 ((M{37Cl, 35Cl}-C4H8N-CH3)+, 18), 338
(14), 337 ([M{35Cl, 35Cl}-C4H8N-CH3]+, 12), 169 (11), 206 (14),
(C6H10N+, 16), 70 (C4H8N+, 18). IR: ν
̃ 2967 (w), 2853 (w),
1609 (s), 1508 (s), 1504 (s), 1474 (m), 1454 (s), 1433 (m), 1371
(s), 1364 (s), 1338 (m), 1327 (m), 1312 (m), 1281 (s), 1260 (m),
1234 (s), 1219 (s), 1198 (m), 1138 (s), 1113 (s), 1105 (s), 1084
(m), 1059 (m), 984 (m), 962 (m), 908 (w), 883 (m), 872 (s),
856 (m), 849 (m), 802 (w), 777 (w), 762 (m), 731 (s), 723
(s), 702 (m), 679 (w), 652 (w) [cm-1]. HR-MS (ESI) calcd.
for C18H1535Cl2N3S+H+: 376.0437; Found: 376.0438.
156 (12), 155 (15). IR: ν̃ 2976 (w), 2953 (w), 2927 (w), 2903
(E)-2-(2-(pyrrolidin-1-yl)vinyl)-3-(thiophen-2-
(w), 2874 (w), 2851 (w), 1605 (m), 1530 (m), 1506 (s), 1479
(m), 1454 (m), 1427 (w), 1381 (m), 1362 (m), 1337 (m), 1306
(m), 1279 (m), 1258 (m), 1238 (m), 1219 (w), 1209 (m), 1186
(m), 1171 (m), 1153 (m), 1101 (m), 1084 (m), 1036 (m), 1018
(w), 986 (m), 966 (m), 951 (m), 928 (m), 908 (w), 883 (s),
808 (w), 750 (m), 739 (s), 673 (m), 654 (m) [cm-1]. Anal.
yl)benzo[g]quinoxaline (9i). Violet solid (439 mg, 61%),
1
Mp 150 °C. H NMR (CDCl3, 300 MHz):
δ 1.90-2.05 (m, 4
H), 3.42 (br, 4 H), 5.79 (d, J = 12.5 Hz, 1 H), 7.17 (dd, J = 5.1
Hz, J = 3.7 Hz, 1 H), 7.34-49 (m, 2 H), 7.51 (dd, J = 5.1 Hz, J
= 1.1 Hz, 1 H), 7.79 (dd, J = 3.7 Hz, J = 1.1 Hz, 1 H), 7.92-8.00
(m, 2 H), 8.24 (2, 1 H), 8.27 (d, J = 12.5 Hz, 1 H), 8.43 (s, 1
ACS Paragon Plus Environment